NPR (7/22, Smith) reports researchers say that while many people who fear Alzheimer’s disease “dismiss memory problems or other symptoms rather than investigate them,” but “that may soon change” as scientists make “progress in measuring beta-amyloid and other Alzheimer’s biomarkers in blood that might eventually be able to reliably, inexpensively and noninvasively identify the disease years before cognitive symptoms develop.” Although now “PET scans for beta-amyloid still aren’t widely available,” John Morris, Alzheimer’s researcher and professor at Washington University in St. Louis, “thinks these physiological measurements will signal a new chapter in Alzheimer’s care.” (SOURCE: APA Headlines)